Jacquelyn Quin1, John Lucke2, Brack Hattler3, Sandeep Gupta4, Janet Baltz5, Muath Bishawi6, G Hossein Almassi7, Frederick L Grover8, Joseph Collins9, A Laurie Shroyer10. 1. Surgery Service, Veterans Affairs (VA) Boston Healthcare System, West Roxbury, Massachusetts. 2. Surgery Service, Charles George VA Medical Center, Asheville, North Carolina. 3. Medicine Service, Department of VA Eastern Colorado Health Care System, Denver4Department of Medicine, University of Colorado School of Medicine-Anschutz Medical Campus, Aurora. 4. Surgery Service, Northport VA Medical Center and Stony Brook University, Stony Brook, New York. 5. Surgery Service, Department of VA Eastern Colorado Health Care System, Denver. 6. Surgery Service, Northport VA Medical Center and Stony Brook University, Stony Brook, New York6currently with Division of Cardiothoracic Surgery, Department of Surgery, Duke University Hospital, Durham, North Carolina. 7. Surgery Service, Milwaukee VA Medical Center, Milwaukee, Wisconsin. 8. Surgery Service, Department of VA Eastern Colorado Health Care System, Denver9Department of Surgery, University of Colorado School of Medicine-Anschutz Medical Campus, Aurora. 9. Cooperative Studies Program Coordinating Center and VA Medical Center, Perry Point, Maryland. 10. Surgery Service, Northport VA Medical Center and Stony Brook University, Stony Brook, New York7Surgery Service, Department of VA Eastern Colorado Health Care System, Denver.
Abstract
IMPORTANCE: Transit time flow (TTF) probes may be useful for predicting long-term graft patency and assessing grafts intraoperatively in patients undergoing coronary artery bypass grafting (CABG); however, studies of TTF probe use are limited. OBJECTIVE: To examine 1-year graft patency and intraoperative revision rates in patients undergoing CABG based on intraoperative TTF assessment. DESIGN, SETTING, AND PARTICIPANTS: Retrospective analysis of a multicenter randomized clinical trial conducted at 18 Veterans Affairs hospitals using the Randomized On/Off Bypass (ROOBY) Trial data set. Of the original 2203 patients undergoing CABG surgery with or without cardiopulmonary bypass from February 1, 2002, through May 31, 2008, we studied a subset of 1607 who underwent TTF probe analysis of 1 or more grafts during surgery. EXPOSURES: Use of TTF probes to assess graft flow and pulsatility index (PI) values. The decision to revise a graft was based on the judgment of the attending surgeon. MAIN OUTCOMES AND MEASURES: Rates of 1-year FitzGibbon grade A patency and intraoperative revision were compared based on TTF measurements (<20 [low flow] vs ≥20 mL/min [normal flow]) and PI values (<3, 3-5, and >5). RESULTS: We measured TTF and/or PI in 2738 grafts, and 1-year patency was determined in 1710 (62.5%) of these grafts. FitzGibbon gradeA patency occurred significantly less often in grafts with a TTF with low flow (259 of 363 [71.3%]) than in those with normal flow (1174 of 1347 [87.2%]; P < .01). FitzGibbon gradeA patency was also inversely correlated with increasing PI values, as found in 936 of 1093 grafts (85.6%) with a PI less than 3, 136 of 182 grafts (74.7%) with a PI of 3 to 5, and 91 of 134 grafts (67.9%) with a PI greater than 5 (P ≤ .01). Intraoperative graft revision was more frequent in grafts with low flow (44 of 568 [7.7%]) than in those with normal flow (8 of 2170 [0.4%]; P < .01). Graft revision was also more frequent as PI increased (12 of 1827 [0.7%] with a PI <3, 9 of 307 [2.9%] with a PI 3-5, and 9 of 155 [5.8%] with a PI >5; P < .01). CONCLUSIONS AND RELEVANCE: Intraoperative TTF probe data may be helpful in predicting long-term patency and in the decision of whether to revise a questionable graft for patients undergoing CABG surgery.
RCT Entities:
IMPORTANCE: Transit time flow (TTF) probes may be useful for predicting long-term graft patency and assessing grafts intraoperatively in patients undergoing coronary artery bypass grafting (CABG); however, studies of TTF probe use are limited. OBJECTIVE: To examine 1-year graft patency and intraoperative revision rates in patients undergoing CABG based on intraoperative TTF assessment. DESIGN, SETTING, AND PARTICIPANTS: Retrospective analysis of a multicenter randomized clinical trial conducted at 18 Veterans Affairs hospitals using the Randomized On/Off Bypass (ROOBY) Trial data set. Of the original 2203 patients undergoing CABG surgery with or without cardiopulmonary bypass from February 1, 2002, through May 31, 2008, we studied a subset of 1607 who underwent TTF probe analysis of 1 or more grafts during surgery. EXPOSURES: Use of TTF probes to assess graft flow and pulsatility index (PI) values. The decision to revise a graft was based on the judgment of the attending surgeon. MAIN OUTCOMES AND MEASURES: Rates of 1-year FitzGibbon grade A patency and intraoperative revision were compared based on TTF measurements (<20 [low flow] vs ≥20 mL/min [normal flow]) and PI values (<3, 3-5, and >5). RESULTS: We measured TTF and/or PI in 2738 grafts, and 1-year patency was determined in 1710 (62.5%) of these grafts. FitzGibbon grade A patency occurred significantly less often in grafts with a TTF with low flow (259 of 363 [71.3%]) than in those with normal flow (1174 of 1347 [87.2%]; P < .01). FitzGibbon grade A patency was also inversely correlated with increasing PI values, as found in 936 of 1093 grafts (85.6%) with a PI less than 3, 136 of 182 grafts (74.7%) with a PI of 3 to 5, and 91 of 134 grafts (67.9%) with a PI greater than 5 (P ≤ .01). Intraoperative graft revision was more frequent in grafts with low flow (44 of 568 [7.7%]) than in those with normal flow (8 of 2170 [0.4%]; P < .01). Graft revision was also more frequent as PI increased (12 of 1827 [0.7%] with a PI <3, 9 of 307 [2.9%] with a PI 3-5, and 9 of 155 [5.8%] with a PI >5; P < .01). CONCLUSIONS AND RELEVANCE: Intraoperative TTF probe data may be helpful in predicting long-term patency and in the decision of whether to revise a questionable graft for patients undergoing CABG surgery.
Authors: Daniel J F M Thuijs; Margreet W A Bekker; David P Taggart; A Pieter Kappetein; Teresa M Kieser; Daniel Wendt; Gabriele Di Giammarco; Gregory D Trachiotis; John D Puskas; Stuart J Head Journal: Eur J Cardiothorac Surg Date: 2019-10-01 Impact factor: 4.191